Listed

Maximus, Inc.: Form 10-Q for the period ended Dec 31, 2023

Filed with the SEC on Feb 8, 2024 and accepted by EDGAR at Feb 8, 2024, 18:10 ET.

Share

Management's discussion and analysis

As filed, 32,400 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Special Note Regarding Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2023 filed with the Securities and Exchange Commission on November 16, 2023 (the "2023 Form 10-K") and elsewhere in this Quarterly Report on Form 10-Q, as applicable.

Business Overview

Maximus, under its mission of Moving People Forward, helps millions of people access the vital government services they need. With over 45 years of experience working with local, state, federal, and international government clients, we proudly design, develop, and deliver innovative and impactful programs that change lives. We are driven to strengthen communities and improve the lives of those we serve.

We create value to our customers through our ability to translate health and human services public policy into operating models that achieve outcomes for governments at scale. Our work covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. These services benefit from a market with increasing demographic demand, constrained government budgets, and an increased focus on technology. We have also shown the ability to move quickly, most notably with the swift establishment of public health and safety initiatives during the recent COVID-19 pandemic, such as vaccine information hotlines and unemployment insurance services. Our organic growth through increased contract scope and entry into new markets has been supplemented by strategic acquisitions. Most notably, our recent acquisitions of VES Group, Inc. ("VES"), a leading provider of medical disability examinations ("MDE") to the United States ("U.S.") Department of Veterans Affairs ("VA"); the Federal business of Attain, LLC ("Attain"), a provider of technology consulting and systems integration services; and a service contract with the U.S. Department of Education, rebranded as "Aidvantage," have supplemented our organic growth and allowed expansion into new markets.

In fiscal year 2022, we introduced our refreshed three-to-five-year strategic plan, which we believe will further expand our business. Having moved past the impacts of the COVID-19 pandemic, we believe we are in a strong position to capitalize on organic growth opportunities in our core business, as reflected in the following three pillars of our refreshed strategy.

  • Customer Services, Digitally Enabled. Elevate the customer experience to achieve higher levels of satisfaction, performance, and outcomes through intelligent automation and cognitive computing.
  • Future of Health. Help governments reach the rising demand for health services by growing our clinical capabilities to improve the health of people and their communities.
  • Advanced Technologies for Modernization. Further our credibility as a technology leader, enabling the transformation of government programs to be resilient, dynamic, integrated, and equitable.

Financial Overview

A number of factors have affected our results for the first quarter of fiscal year 2024. More detail on these changes is presented below within our "Results of Operations" section.

Results of Operations

The following table sets forth items from our consolidated statements of operations for the three months ended December 31, 2023 and December 31, 2022.

Table MD&A 1: Consolidated Results of Operations

(dollars in thousands, except per share data)

For the Three Months Ended December 31, 2023 December 31, 2022
Revenue $1,327,041 $1,249,246
Cost of revenue 1,026,987 1,004,499
Gross profit 300,054 244,747
Gross profit percentage 22.6 % 19.6 %
Selling, general, and administrative expenses 169,195 146,452
Selling, general, and administrative expenses as a percentage of revenue 12.7 % 11.7 %
Amortization of intangible assets 23,349 23,518
Operating income 107,510 74,777
Operating margin 8.1 % 6.0 %
Interest expense 21,507 21,606
Other expense/(income), net 488 (266)
Income before income taxes 85,515 53,437
Provision for income taxes 21,367 13,442
Effective tax rate 25.0 % 25.2 %
Net income $64,148 $39,995
Earnings per share:
Basic $1.05 $0.65
Diluted $1.04 $0.65

Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.

Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended December 31, 2023

(dollars in thousands)

Revenue Dollars % Change Cost of Revenue Dollars % Change Gross Profit Dollars % Change
Three Months Ended December 31, 2022 $1,249,246 $1,004,499 $244,747
Organic effect 86,799 6.9% 32,835 3.3% 53,964 22.0%
Disposal of businesses (13,736) (1.1)% (14,608) (1.5)% 872 0.4%
Currency effect compared to the prior period 4,732 0.4% 4,261 0.4% 471 0.2%
Three Months Ended December 31, 2023 $1,327,041 6.2% $1,026,987 2.2% $300,054 22.6%

21

Selling, general, and administrative expenses ("SG&A")

Selling, general, and administrative expenses ("SG&A") consist of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.

Our SG&A expense increased by $22.7 million year-over-year, primarily driven by growth in our business, including additional spending in anticipation of future work.

Amortization of intangible assets

Our intangible asset amortization for the three months ended December 31, 2023 is consistent with the comparative period in fiscal year 2023.

On December 15, 2023, the Department of Health and Human Services publicly announced that the Centers for Medicare & Medicaid Services (CMS) will recompete the Call Center Operations (CCO) contract to include a labor harmony agreement. We are currently in the second option period of the contract and have operated the program since 2018. No timeline has been disclosed on future actions by the government, including a Request For Proposal release date. Until a recompete process is complete, which typically takes a year or more for a contract of this size and complexity, we expect to continue work uninterrupted on the current contract.

Our balance sheet includes a $41.6 million customer-relationship intangible asset with a five-year remaining life related to this contract which was part of the 2018 acquisition of General Dynamics Information Technology (GDIT) contact centers. In the event that our expectations change with respect to this contract, the value of this asset or its estimated remaining life may need to be adjusted.

Interest Expense

Our interest expense has remained consistent year-over-year as declines in our debt balance are offset by increased interest rates. We have mitigated our risk by fixing interest rates on approximately half of our debt and our near-term capital allocation plan continues to prioritize reducing our debt using our free cash flow.

Provision for Income Taxes

Our effective income tax rate for the three months ended December 31, 2023 and 2022, was 25.0% and 25.2%, respectively. For fiscal year 2024, we expect the effective tax rate to be between 24.5% and 25.5%.

U.S. Federal Services Segment

Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This segment also includes appeals and assessments services, system and application development, Information Technology ("IT") modernization, and maintenance services. Certain state-based assessments and appeals work that is part of the segment's heritage continues to be managed within this segment. Under Technology Consulting Services ("TCS"), the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions through VES, which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs ("VA").

Table MD&A 3: U.S. Federal Services Segment - Financial Results

(dollars in thousands)

For the Three Months Ended December 31, 2023 December 31, 2022
Revenue $677,078 $618,167
Cost of revenue 520,416 495,473
Gross profit 156,662 122,694
Selling, general, and administrative expenses 87,855 71,649
Operating income 68,807 51,045
Gross profit percentage 23.1% 19.8%
Operating margin percentage 10.2% 8.3%

Our revenue and cost of revenue for the three months ended December 31, 2023, increased 9.5% and 5.0%, respectively, compared to the three months ended December 31, 2022. All growth in the first quarter of fiscal year 2024 was organic.

As anticipated, much of this growth was driven by increased volumes on expanded programs, including the U.S. Department of VA's Medical Disability Examinations ("MDE") contracts.

Our profit margins have improved period-over-period. Our results in the first quarter of fiscal year 2023 reflected hiring and staffing costs in anticipation of higher volumes, thus tempering margins. Our results in fiscal year 2024 reflect those anticipated volumes. We anticipate full-year operating margin will range between 11% and 12%.

U.S. Services Segment

Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Over the last three years, many programs in this segment have been operating with depressed margins resulting from the pause in Medicaid redeterminations. The depressed margins have resulted from reduced operating leverage in the segment as costs could not scale down at the same rate to meet lower demand due to requirements to fulfill other obligations on these contracts. Now that redetermination activities have resumed, we expect fiscal year 2024 and beyond to reflect a recovery of operating leverage.

Table MD&A 4: U.S. Services Segment - Financial Results

(dollars in thousands)

For the Three Months Ended December 31, 2023 December 31, 2022
Revenue $489,845 $439,478
Cost of revenue 371,482 355,880
Gross profit 118,363 83,598
Selling, general, and administrative expenses 52,300 45,842
Operating income 66,063 37,756
Gross profit percentage 24.2% 19.0%
Operating margin percentage 13.5% 8.6%

Our revenue and cost of revenue for the three months ended December 31, 2023, increased 11.5% and 4.4%, respectively, compared to the three months ended December 31, 2022. All growth in the first quarter of fiscal year 2024 was organic.

This segment received the benefit of expanded eligibility support and clinical services programs, as well as the resumption of Medicaid redetermination activities.

Profit margins in fiscal year 2023 reflected the pause in redetermination activities, which have since been resumed. We anticipate our full-year operating margin will range between 11% and 12%.

Outside the U.S. Segment

Our Outside the U.S. Segment provides BPS for international governments, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. We support programs and deliver services in the United Kingdom, including the Health Assessment Advisory Service ("HAAS") and the recently awarded replacement contract to start in 2024, Functional Assessment Services (“FAS”), and Restart; Australia, including Workforce Australia and employment support and job seeker services worldwide.

Table MD&A 5: Outside the U.S. Segment - Financial Results

(dollars in thousands)

For the Three Months Ended December 31, 2023 December 31, 2022
Revenue $160,118 $191,601
Cost of revenue 135,089 153,146
Gross profit 25,029 38,455
Selling, general, and administrative expenses 25,141 28,389
Operating (loss)/income (112) 10,066
Gross profit percentage 15.6% 20.1%
Operating margin percentage (0.1)% 5.3%

Table MD&A 6: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue and Gross Profit

(dollars in thousands)

Revenue Amount % Change Cost of Revenue Amount % Change Gross Profit Amount % Change
Three Months Ended December 31, 2022 $191,601 $153,146 $38,455
Organic effect (22,479) (11.7)% (7,710) (5.0)% (14,769) (38.4)%
Disposal of businesses (13,736) (7.2)% (14,608) (9.5)% 872 2.3%
Currency effect compared to the prior period 4,732 2.5% 4,261 2.8% 471 1.2%
Three Months Ended December 31, 2023 $160,118 (16.4)% $135,089 (11.8)% $25,029 (34.9)%

This segment recorded a break-even margin in the first quarter of fiscal year 2024 as management undertakes steps to improve performance and deliver consistent profitability in this part of our organization. These steps included the divestiture in fiscal year 2024 of our employment services business in Canada and all of our operations in Italy and Singapore. In fiscal year 2023, we disposed of our commercial practice in the United Kingdom and our Swedish operations.

In the first quarter of fiscal year 2023, this segment received a significant benefit from higher employment services volumes, which did not recur. Revenue from our employment services contracts include payments based upon our ability to place individuals in long-term, sustained employment. We recognize this revenue over the period of performance using estimates of these outcomes, which are typically based upon past performance. Changes in these estimates may have a significant effect on our revenue.

We anticipate our Outside the United States Segment will yield slightly above break-even operating margin for the full year.

Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of December 31, 2023, we had $104.2 million in cash and cash equivalents. We believe that our current cash position, access to our revolving debt, and cash flow generated from operations should be sufficient for our operating requirements for the next 12 months and beyond, including enabling us to fund required long-term debt repayments, dividends and any share purchases we might choose to make. See "Note 6. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.

We have included the following table showing our debt balances as of December 31, 2023, and their effective interest rates.

Table MD&A 7: Balances and interest rates as of December 31, 2023

(dollars in thousands)

December 31, 2023 Carrying value Effective cash interest rate Interest rate basis
Term Loan A - Unhedged $238,750 6.96% Term SOFR reset monthly plus margin. (1)
Term Loan A - Hedged though May 2026 500,000 3.91% Fixed rate of 2.31% plus margin. (1)
Term Loan A - Hedged through September 2024 150,000 5.98% Fixed rate of 4.48% plus margin. (1)
Term Loan B 344,052 7.46% Term SOFR (variable reset) plus 2% margin.
Revolver 80,000 6.96% Term SOFR reset monthly plus margin. (1)
Debt held by international subsidiaries 6,818 6.14% Floating rate, reset quarterly.
Debt Principal $1,319,620

(1) Applicable margin ranges between 1% and 2%, based on our leverage ratio.

Our effective cash interest rate reflects the drivers of our cash interest payments as of December 31, 2023, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of December 31, 2023 is 6.0%.

The below table summarizes our change in cash, cash equivalents, and restricted cash.

Table MD&A 8: Net Change in Cash and Cash Equivalents and Restricted Cash

(in thousands)

Operating activities: For the Three Months Ended December 31, 2023 December 31, 2022
Net cash provided by/(used in) operating activities $21,608 $(134,659)
Net cash used in investing activities (20,432) (15,697)
Net cash provided by financing activities 28,382 170,967
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 1,846 2,421
Net change in cash and cash equivalents and restricted cash $31,404 $23,032

Net Cash Provided By/Used In Operating Activities

Net cash from operations was $21.6 million in the first quarter of fiscal year 2024, compared with a cash outflow of $134.7 million in the first quarter of fiscal year 2023.

  • Cash collections were stronger than usual in the the first quarter of the current year, with our Days Sales Outstanding ("DSO") remaining steady between September 30, 2023, and December 31, 2023 at 60 days and 59 days, respectively. Our DSO at September 30, 2022 and December 31, 2022, were 62 days and 74 days, respectively, with slower payments in the first quarter catching up in the second quarter of fiscal year 2023.
  • In fiscal year 2023, we also made payroll tax payments that had been deferred as part of pandemic-related relief measures, as well as higher income tax payments, which did not occur in the first quarter of fiscal year 2024.

Net Cash Used In Investing Activities

Investing activities in the first quarter of fiscal years 2024 and 2023 include significant investments in internal-use software, as well as standard purchases of property and equipment. In the first quarter of fiscal year 2024, we received payments for the sale of businesses disposed of in the quarter, as well as an installation on the sale of our United Kingdom commercial practice.

Net Cash Provided By Financing Activities

Our net borrowings in the first quarter of fiscal year 2024 were lower than the same prior year period, due to the improved cash collections.

Credit Facilities

Our principal debt agreement is with JPMorgan Chase Bank N.A. (the "Credit Agreement"). At December 31, 2023, we owed $1.31 billion under the Credit Agreement, with access to an additional $520 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2028, when the agreement ends, and must be renegotiated or the funds repaid.

The Credit Agreement contains a number of covenants with which we are expected to comply. Failure to meet these requirements would result in a need to renegotiate the agreement or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement.

  • Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt, offset by up to $75 million of unrestricted cash (Consolidated Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the leverage ratio increases.
  • Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.

Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.

Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals, and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly-titled measures presented by other companies.

We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement, which are included within our financial statements. At December 31, 2023, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction in our ability to operate our business or to pay our dividends.

Table MD&A 9: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement

(in thousands)

For the Three Months Ended December 31, 2023 For the Trailing Twelve Months Ended December 31, 2023
Net income $64,148 $185,945
Adjustments:
Interest expense 21,507 84,039
Other expense, net 488 1,117
Provision for income taxes 21,367 56,426
Amortization of intangibles 23,349 94,422
Stock compensation expense 9,427 34,546
Acquisition-related expenses 1,724 905
Loss on sale of businesses 1,018 1,901
Depreciation and amortization of property, equipment, and capitalized software 8,411 50,856
Pro forma and other adjustments permitted by our Credit Agreement 13,940 70,202
Consolidated EBITDA (as defined by our Credit Agreement) $165,379 $580,359

26

(in thousands, except ratio data)

Table MD&A 10: Consolidated Net Total Leverage Ratio For the Trailing Twelve Months Ended December 31, 2023
Funded Debt (as defined by our Credit Agreement) $1,319,620
Cash and cash equivalents up to $75 million 75,000
Consolidated Net Total Leverage (as defined by our Credit Agreement) $1,244,620
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement) 2.14

(in thousands, except ratio data)

Table MD&A 11: Consolidated Net Interest Coverage Ratio For the Trailing Twelve Months Ended December 31, 2023
Consolidated EBITDA (as defined by our Credit Agreement) $580,359
Interest expense 84,039
Components of other income/expense, net allowed in ratio calculation 3,061
Consolidated Net Interest Expense (as defined by our Credit Agreement) 87,100
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement) 6.66

Cash in Foreign Locations

We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.

Free Cash Flow (Non-GAAP)

Table MD&A 12: Free Cash Flow (Non-GAAP)

(in thousands)

For the Three Months Ended December 31, 2023 December 31, 2022
Net cash provided by/(used in) operating activities $21,608 $(134,659)
Purchases of property and equipment and capitalized software (22,247) (15,697)
Free cash flow (Non-GAAP) $(639) $(150,356)

27

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2023 Form 10-K, as filed with the SEC on November 16, 2023, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the three months ended December 31, 2023.

Non-GAAP and Other Measures

We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

For the three months ended December 31, 2023, 12% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal period's results for all foreign businesses using the exchange rates in the prior fiscal period.

In recent years, we have made a number of acquisitions and divestitures. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal period results excluding transactions from acquisitions or disposals, to our prior fiscal year period results.

Our recent acquisitions have resulted in significant intangible assets, which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. For the three months ended December 31, 2023, we also incurred losses on sales of businesses. We believe that providing supplemental measures that exclude the impact of the items detailed below is useful to investors in evaluating our core operations and results in relation to past periods. Accordingly, we have calculated our operating income, net income, and diluted earnings per share, excluding the effect of the amortization of intangible assets and divestiture-related charges. We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.

Table MD&A 13: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets

(dollars in thousands, except per share data)

For the Three Months Ended December 31, 2023 December 31, 2022
Operating income $107,510 $74,777
Add back: Amortization of intangible assets 23,349 23,518
Add back: Divestiture-related charges 1,018 —
Adjusted operating income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $131,877 $98,295
Adjusted operating income margin excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) 9.9% 7.9%
Net income $64,148 $39,995
Add back: Amortization of intangible assets, net of tax 17,208 17,360
Add back: Divestiture-related charges 1,018 —
Adjusted net income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $82,374 $57,355
Diluted earnings per share $1.04 $0.65
Add back: Effect of amortization of intangible assets on diluted earnings per share 0.28 0.29
Add back: Effect of divestiture-related charges on diluted earnings per share 0.02 —
Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $1.34 $0.94

In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

Market risk

As filed, 517 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2023 Form 10-K, as filed with the SEC on November 16, 2023, have not changed materially during the three month period ended December 31, 2023.

Controls and procedures

As filed, 1,542 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 187 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There were no material changes during the three months ended December 31, 2023, to the risk factors previously disclosed in the 2023 Form 10-K, as filed with the SEC on November 16, 2023.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-10-01 to 2023-12-31$1.33bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2023-10-01 to 2023-12-31$1.03bnus-gaap:CostOfRevenue
Gross profit3 months2023-10-01 to 2023-12-31$300.1mus-gaap:GrossProfit
Selling, general and administrative3 months2023-10-01 to 2023-12-31$169.2mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2023-10-01 to 2023-12-31$107.5mus-gaap:OperatingIncomeLoss
Income tax3 months2023-10-01 to 2023-12-31$21.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2023-10-01 to 2023-12-31$64.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2023-10-01 to 2023-12-31$1.04us-gaap:EarningsPerShareDiluted
Basic EPS3 months2023-10-01 to 2023-12-31$1.05us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2023-10-01 to 2023-12-3161,535,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2023-10-01 to 2023-12-31$21.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2023-10-01 to 2023-12-31$22.2mus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2023-12-31$104.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-12-31$1.11bnus-gaap:AssetsCurrent
Total assetsAt period end2023-12-31$4.02bnus-gaap:Assets
Current liabilitiesAt period end2023-12-31$658.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-12-31$2.30bnus-gaap:Liabilities
Long-term debtAt period end2023-12-31$1.22bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2023-12-31$90.4mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2023-12-31$1.72bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001032220-24-000015. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.